Fitxa persona

Resumen CV. ORCID: 0000-0002-3778-0966. Scopus ID: 7004284629 Status: Doctor in Chemistry. University of Valencia 1988. Full University Professor since 2009. Teaching activity: Theoretical and practical teaching in all the cycles of the Degree in Chemistry and Pharmacy, master's degree in Experimental Techniques in Chemistry and in Forensic Chemistry. Participation in 7 teaching innovation projects of the University of Valencia and 6 congresses on teaching innovation. From 2011-12 to 2018-19. Research Centers/Groups: (1983-2021) Involved in 6 university centers, 10 research groups (3 international). In 1994 participated in the formation of the research group registered at the University of Valencia GAMM-CyBAR (GIUV2013-111), with management research and training responsibilities. In 2010 participated in the constitution of the current Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM), with management and researcher responsibilities. Research activity: Evaluation of research activity: 5 Sexenios of research (1989-2018). Lines of research: Chromatography and capillary electrophoresis, in vitro techniques, pharmacological properties, toxicity, xenobiotics. Enantioselectivity, chemometrics, qualimetrics, predictive models, pharmaceutical preparations, biological fluids, environmental samples. (Bio)degradation of emerging pollutants. Recently, applied artificial intelligence. Directed numerous research projects/works (End of degree, Bachelor's, and Master's degree; 11 Bachelor's Theses, 5 Doctoral Theses -2 European Doctorate and 1 Extraordinary Prize-, as well as 11 FPI- and FPU-Grants, Intercampus, Erasmus scholarship holders, 2 South African students (stay related to Project: HS2008-0002, see below). Dissemination of research results: 152 international research articles (Analytical Chemistry, Medicinal Chemistry, Environment, Computational Science, Modelling), 2 scientific-technical books, 8 book chapters (7 international). Editor of an international book (Ed. Pan Stanford Publishing), 6 international conference proceedings, 190 conference papers (142 international). General quality indicators (Scopus): 2,989 Citations by 1,827 documents H-index: 31. Research Projects and Contracts: Principal Investigator of the Spanish team in 1 Spain-South Africa Integrated Action (MICINN); Project: HS2008-0002 (2009-2010). Involved as researcher in in 7 National Research Projects. SAF96-1709, SAF99-0110, SAF2002-01330, SAF2005-01435, SAF2008-00859 (1996-2011) CTQ2015-70904-R. (2015-2019), 2 local project UV-INV-AE112-66289 (2012-13), UV-INV-AE-2637396 (2023-24) and 6 Regional projects to research groups. Has 4 contracts/collaborations with companies (one of them from 2001 to the present). Transfer of results: Co-inventor of 1 patent: Micellar chromatographic support for bio-repair (PUBLICATION No.: 2 185 453). Mobility: 3 research stays (USA, UK, and South Africa). Research Management: In 2010, participated in the foundation of the Centre for Molecular Recognition and Technological Development (IDM), which in 2015, officially became the Interuniversity Research Institute for Molecular Recognition and Technological Development (IDM). Universitat Politècnica de València, Universitat de València; first Valencian interuniversity center, integrating 115 researchers (2018), of which he is Secretary since 2015 and Deputy Secretary (2020-2022). Member of the Organizing Committee of 2 congresses (1 international). Member of the Technical Committee of 4 international conferences. JOURNAL REVIEWER: Analytical Chemistry, Current Drug metabolism, Analytica Chimica Acta, Talanta, Journal of Chromatography A, Water Research, Chemosphere, among others. Awards: 'Top cited article 2001-2006 Award' for the article: J. Chromatogr. B (2001) 753, 225-236; ELSEVIER (2006). Recognition of professional career in the field of scientific research in biomedicine and health sciences by the President of the Generalitat Valenciana (2010). Acknowledgements: Two articles published in Drug Discovery Today (2004, 1, 431-439 and 2006, 11, 517-523: Impact factor: 7.76 in 2016) reviewed the methodology 'Biopartitioning Micellar Chromatography' (BMC; invented/patented by the GAMM-CyBAR research group) defining it as 'a novel and modern tool to estimate drug hydrophobicity and permeability'..